Today on Outsourcing-Pharma.com   Inyx Pharma gets new life; Ashton awaits fate Inhaled insulin: make or break? Pfizer partners in shock after surprise Exubera exit Icon living up to its name Preclinical services news in brief

Related Industry News   Inhalers failing asthmatics Beer goes flat for Kirin, splashes cash on 'ultimate cancer warrior' instead Vitamin B12 the key to oral insulin? Viagra could cause hearing loss

Breaking News on Outsourcing Pharma
Daily  Tuesday 23 October 2007		Forward to a colleague

	Product Brochure Baxter's contract services case study Baxter's contract services case study details the expedited transfer of a commercial launched lyophilized drug to a new production site. Their team designed solutions resulting in cost savings, yield improvement and cycle optimization... Click Here Access Full Stories Inyx Pharma gets new life; Ashton awaits fate Inyx Pharma has been given a new lease on life after it was bought by another UK firm, finally bringing relief after it was dragged into administration when its US parent company Inyx Inc. ran aground financially... Read Inhaled insulin: make or break? Eli Lilly is remaining optimistic about its yet-to-be-approved inhaled insulin despite the dramatic downfall of Pfizer's Exubera. But is Exubera's fall from grace an indication of things to come for inhaled diabetes... Read Pfizer partners in shock after surprise Exubera exit We've all cringed at stories of people dumping their partners via text message but in the world of business, Pfizer seems to have taken things to a new level when its Exubera partners were allegedly left to find... Read Icon living up to its name Icon is living up to its name, according to a recent contract research organisation (CRO) survey, which also recognised Quintiles and PPD in terms of quality performance... Read Preclinical services news in brief In this week's review of activity within the preclinical research services arena, new deals have emerged involving Cato Research, Genoway, Caliper Life Sciences and Rules-Based Medicine... Read
	All News Headlines for: October | September | August
	Related Industry News Inhalers failing asthmatics Complicated inhaler devices are failing patients according to a recent report, with tricky mechanisms and techniques resulting in low drug delivery and poor disease management... Read Beer goes flat for Kirin, splashes cash on 'ultimate cancer warrior' instead Japan's Kirin Holdings, best-known in the West as a beer maker, will acquire a controlling stake in Kyowa Hakko, and thus get its hands on what Kyowa claims are 'the ultimate antibody warriors' against cancer... Read Vitamin B12 the key to oral insulin? Pfizer may have given up on its non-injectable insulin, but researchers in the US think they may have cracked a way to deliver the hormone orally, linking it up to vitamin B12 to protect it through the digestive... Read Viagra could cause hearing loss The earth may move and the heavens may shake but drug regulators now think Viagra could also make you go deaf... Read Weekly Comment 'We are not anti-Asia' says EU chemicals body There have been more calls this month to tighten regulations on pharmaceutical ingredient suppliers in the wake of the recent safety concerns emanating from low-cost regions such as China and India.  However, despite having recently established a dedicated 'China Taskforce', a major EU chemicals consortium insists that it has nothing against the region or its manufacturers. Read Previous Headlines King trims its court following Altace about-turn King Pharmaceuticals last week announced that it would be cutting 20 per cent of its workforce after the US Court of Appeals reversed a previous court ruling and invalidated a patent covering the firm's blood pressure... Read Pharma outsourcing: people on the move Icon, PPD, Chiltern, Kendle, Omnicare and Aesica have all had people on the move in the world of pharmaceutical outsourcing... Read Discarded body parts used to cut animal testing A team of US scientists have used typically discarded body parts to create a 'joint in a test tube', which they can use to test arthritis drugs instead of using animals... Read Study your rats so the results don't bite New research has shown that even if laboratory rats are genetically identical they can still develop distinct metabolic profiles that could skew drug toxicity and metabolism studies... Read Industry bodies call for EU clinical trials directive changes Two major bioscience industry trade associations have called for changes to be made to the European clinical trials directive in order to bring about "harmonisation, transparency and consistency" in this area across... Read Product Innovation Alerts - Free of Charge Indicate your research interests and receive alerts on relevant products and market innovations Analytical testing, QC Bulk ingredients Contract sales & marketing Data management Drug delivery, formulation Fill & finish, packaging Phase I-II Phase III-IV Preclinical Product & Supplier News - Contract Manufacturing Regulatory affairs Supply chain, logistics Validation services

	Free Newsletters for Pharmaceuticals Access now !Choose from over 20 industry e-newsletters Access Decision News Media e-newsletters for the food, beverage & nutrition industries, click here
	Forward to a colleague

	To continue to receive this newsletter in your inbox, please add newsletter@OutSourcing-Pharma.com to your address book
	Update preferences | Change your email address | Unsubscribe
	Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback
	© 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com